Serpin Pharma, LLC

American Type Culture Collection

University of Georgia Research Foundation, Inc.

Caerus Therapeutics, Inc.

Cohava Gelber

Soren Mogelsvang

Liping Liu

J Michael Pierce

Zhidong Xie

Pranvera Ikonomi

Dana Austin

John R Simms

Catherine R Auge

We describe peptides and their uses for the treatment of autoimmune, inflammatory and metabolic diseases.

Serpin peptides and methods of using the same

Disclosed herein are SERPIN peptides, and analogues and derivatives thereof, and uses of the same for treating various conditions associated with LRP1 mediation.

Peptides and methods of using the same

Provided herein are antibodies and related polypeptides that bind specifically to CEACAM6. The antibodies and/or polypeptides can be configured as bispecific T cell engagers. The antibodies and/or polypeptides can also be configured as chimeric antigen receptors. Also provided are methods of detection and treatment of cancer, for example, pancreatic cancer, using the antibodies and related polypeptides herein.

Antibody constructs and methods of treating cancer

We describe peptides and their uses for the treatment of, e.g. acute myocardial infarction and other cytokine storm-associated conditions.

Methods for treatment of diseases

Peptides and methods of using same

The present invention relates generally to the identification of biological markers associated with an increased risk of developing Diabetes, as well as methods of using such biological markers in diagnosis and prognosis of Diabetes. The biological markers of the invention may indicate new targets for therapy or constitute new therapeutics for the treatment or prevention of Diabetes.

Methods for treatment of type 1 diabetes

Methods for treatment of type 2 diabetes

Growing community of inventors

Nokesville, VA, United States of America

Cohava Gelber